*
stanford arches
left navigation bar
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved. Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
* *
 

Research in Progress

Gene Therapy



RNAi: Recognizing the HD Allele

Each person has two copies, or alleles, of almost every gene. Huntington’s disease (HD) results from an error in one copy of the Huntington gene. The normal copy (the non-HD allele) makes a functional form of the huntingtin protein, while the abnormal copy (the HD allele) makes a harmful form of the protein that contains too much of the amino acid glutamine. This mutant protein tends to form protein aggregates in some nerve cells in the brain. Whether these aggregates are part of the HD disease process, or are simply a result of this process, is not yet known. However, many nerve cells containing aggregates will die in the brains of people with HD.

As mentioned in the previous update, “Fast and Cheap”: siRNA in Gene Silencing, researchers have discovered a way of hindering messenger RNA (mRNA), the “middleman” in the process of converting DNA to protein: they use small interfering pieces of RNA (short interference RNA [siRNA]). This technique is called RNA interference (RNAi). (An important note: the central dogma of molecular biology states that DNA codes for the production of RNA [transcription], which then undergoes translation into proteins. (Please see diagram below.) For more information on genetics, click here. The siRNA recognizes the mRNA transcribed from the HD allele and, with the help of other molecules in the cell, destroys this mRNA. Hence, the defective copy of the gene cannot be translated into a harmful protein. The normal copy of the gene remains intact and continues to code for the normal huntingtin protein.

The researchers’ next challenge is delivering the siRNA to the degenerating nerve cells, which requires something (such as a harmless virus or virus segment) that can transport it across the blood-brain barrier. Once they find a suitable chemical or mechanism to carry the siRNA to the nerve cells, they may be able to begin using RNAi therapy to treat HD.

To read more about RNAi, please click here and here.

Fig AE-1: The central dogma of molecular biology
Fig AE-1: The central dogma of molecular biology
The central dogma of molecular biology describes the flow of genetic information from DNA to RNA to protein. The tongue-in-cheek term “central dogma” -not to be confused with religious dogma- was coined by Francis Crick (of Watson and Crick, the two scientists who discovered the double helix structure of DNA).

prevback to chapter titlenext

Last Modified: 05/22/2009


HOPES Logo

An educational product of HOPES, not to be used in place of medical care.
For more information about HOPES, click on the Logo.
To contact HOPES with comments or questions, click here.


You are HOPES site visitor number

 
corner  corner
corner corner
HDSA Honors
HDSA Award Logo

The "Giving a Voice to HD" Award
corner corner
corner corner
Interactive HOPES
More Interactive HOPES>>>
corner corner
corner corner
Search HOPES
corner corner
corner corner
Esperanzas/Espoirs/
Other Languages
corner corner
corner  corner
 About HOPES    Home    Site Search    Glossary    Contact Us   
corner  corner
DHTML Web Menu by OpenCube